Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy

被引:38
|
作者
Baslaim, MM
Al Malik, OA
Al-Sobhi, SS
Ibrahim, E
Ezzat, A
Ajarim, D
Tulbah, A
Chaudhary, MA
Sorbris, RA
机构
[1] King Faisal Specialist Hosp & Res Ctr, Dept Surg, Riyadh 11211, Saudi Arabia
[2] King Fahad Cent Hosp, Dept Surg, Jeddah, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Dept Oncol, Riyadh 11211, Saudi Arabia
[4] King Faisal Specialist Hosp & Res Ctr, Dept Pathol, Riyadh 11211, Saudi Arabia
[5] King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Sci Comp, Riyadh 11211, Saudi Arabia
来源
AMERICAN JOURNAL OF SURGERY | 2002年 / 184卷 / 04期
关键词
axillary lymph node retrieval; neoadjuvant chemotherapy; locally advanced breast cancer;
D O I
10.1016/S0002-9610(02)00959-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The purpose of this study was to assess our clinical impression that fewer lymph nodes are retrieved after level I and H axillary dissection after neoadjuvant chemotherapy and whether there is a positive correlation between the total number of lymph nodes retrieved and the number of diseased lymph nodes. Methods: Patients included those with stage IIB, IIIA, and IIIB breast cancer of whom 77 had neoadjuvant chemotherapy and 58 had initial surgery only. All had modified radical mastectomy with in continuity level I and II axillary dissection. Results: Patients after neoadjuvant chemotherapy had 14.3 +/- 6.7 lymph nodes detected versus 16.9 +/- 8.8 (mean +/- SD; P < 0.057) for those with initial surgery only. The number of positive nodes were 3.7 +/- 4.7 versus 6.6 +/- 8.7 (mean +/- SD; P < 0.033) respectively and the number of negative nodes were 10.6 +/- 7.5 versus 10.4 +/- 8 (mean +/- SD; P < 0.9). The correlation between the number of positive lymph nodes and the total number of lymph nodes was r = 0.58; P < 0.001. Conclusions: It appears that fewer lymph nodes are retrieved after level I and II axillary dissection after neoadjuvant chemotherapy. The total number of lymph nodes retrieved increases directly with the number of positive lymph nodes in patients not treated with chemotherapy. (C) 2002 Excerpta Medica, Inc. All rights reserved.
引用
收藏
页码:299 / 301
页数:3
相关论文
共 50 条
  • [1] Evaluating Axillary Lymph Node Yield After Neoadjuvant Chemotherapy
    Fan, Betty
    Romatoski, Kelsey
    Pardo, Jaime
    Valero, Monica
    Serres, Stephanie
    Flores, Rene
    James, Ted
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (01) : 107 - 111
  • [2] Axillary lymph node count is lower after neoadjuvant chemotherapy
    Neuman, Heather
    Carey, Lisa A.
    Ollila, David W.
    Livasy, Chad
    Calvo, Benjamin F.
    Meyer, Anthony A.
    Kim, Hong Jin
    Meyers, Michael O.
    Dees, E. Claire
    Collichio, Fran A.
    Sartor, Carolyn I.
    Moore, Dominic T.
    Sawyer, Lynda R.
    Frank, Jill
    Klauber-DeMore, Nancy
    [J]. AMERICAN JOURNAL OF SURGERY, 2006, 191 (06): : 827 - 829
  • [3] Sentinel Lymph Node Detection In Patients With Breast Cancer And Positive Axillary Lymph Node After Neoadjuvant Chemotherapy
    Carcamo-Ibarra, P.
    Rodriguez-Parra, H.
    Redal-Pena, M.
    Casans-Tormo, I.
    Carrero-Vasquez, V.
    Canoves-Llombart, A.
    Sabater-Sancho, J.
    Lopez-Gonzalez, U.
    Soria-Merino, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S611 - S611
  • [4] Axillary lymph node recurrence and prognosis of avoiding axillary lymph node dissection by sentinel lymph node biopsy after neoadjuvant chemotherapy
    Kajiwara, Y.
    Kin, T.
    Fujihara, M.
    Yoshimura, Y.
    Ito, M.
    Ohtani, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 57 : S75 - S75
  • [5] Sentinel lymph node biopsy as an alternative to axillary lymph node dissection after neoadjuvant chemotherapy
    不详
    [J]. EJC SUPPLEMENTS, 2006, 4 (02): : 73 - 73
  • [6] Accurate axillary lymph node dissection is feasible after neoadjuvant chemotherapy
    Straver, Marieke E.
    Rutgers, Emiel J. T.
    Oldenburg, Hester S. A.
    Wesseling, Jelle
    Linn, Sabine C.
    Russell, Nicola S.
    Peeters, Marie-Jeanne T. F. D. Vrancken
    [J]. AMERICAN JOURNAL OF SURGERY, 2009, 198 (01): : 46 - 50
  • [7] Radiation after axillary lymph node dissection: impact of neoadjuvant chemotherapy
    Kirstein, L. J.
    MacDonald, S.
    Abi Raad, R.
    Taghian, A. G.
    Smith, B. L.
    Specht, M. C.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S240 - S240
  • [8] Omission of Axillary Lymph Node Dissection in Patients with Residual Nodal Disease After Neoadjuvant Chemotherapy
    Limberg, Jessica N.
    Jones, Tyler
    Thomas, Samantha M.
    van den Bruele, Astrid M. Botty
    Wang, Ton
    Plichta, Jennifer K.
    Rosenberger, Laura H.
    DiNome, Maggie L.
    Chiba, Akiko
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S89 - S90
  • [9] Omission of Axillary Lymph Node Dissection in Patients with Residual Nodal Disease After Neoadjuvant Chemotherapy
    Limberg, Jessica N.
    Jones, Tyler
    Thomas, Samantha M.
    Ntowe, Koumani W.
    Dalton, Juliet C.
    van den Bruele, Astrid Botty
    Wang, Ton
    Plichta, Jennifer K.
    Rosenberger, Laura H.
    Dinome, Maggie L.
    Chiba, Akiko
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024,
  • [10] Prognostic impact of axillary lymph node status after neoadjuvant chemotherapy for patients with breast cancer
    Nakamura, R.
    Yamamoto, N.
    Miyaki, T.
    Itami, M.
    [J]. CANCER RESEARCH, 2019, 79 (04)